This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Glaucoma or Open Angle or Ocular Hypertension
and you are
over 18
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The main purpose of this prospective study is to demonstrate the therapeutic equivalence of topical brinzolamide dosed three times daily compared with AzoptTM (brinzolamide ophthalmic suspension 1%) dosed three times daily in IOP reduction in patients with POAG or OH.

Provided treatments

  • Drug: brinzolamide 1% ophthalmic suspension
  • Drug: Azopt 1%

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01722604. The sponsor of the trial is Bausch Health Americas, Inc. and it is looking for 258 volunteers for the current phase.
Official trial title: